These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 16216175)
61. [Inflammatory pathologies of the rhinosinusitis: rationale for the use of anti-inflammatory agents]. Bellussi L Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):21-5, 37-40. PubMed ID: 15058606 [No Abstract] [Full Text] [Related]
62. Long-term macrolide treatment for chronic respiratory disease. Spagnolo P; Fabbri LM; Bush A Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583 [TBL] [Abstract][Full Text] [Related]
63. Recent Understanding of Role of Macrolides in Rhinosinusitis. Kim CH Jpn J Antibiot; 2013 Jul; 67 Suppl A():53. PubMed ID: 26688956 [No Abstract] [Full Text] [Related]
64. Efficacy of controlling rhinosinusitis on the prevention of complications in pituitary surgery with transsphenoidal approach. Bae WY; Kim SH; Kang MY; Koh TK Auris Nasus Larynx; 2014 Feb; 41(1):50-2. PubMed ID: 23911235 [TBL] [Abstract][Full Text] [Related]
65. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Rimmer J; Fokkens W; Chong LY; Hopkins C Cochrane Database Syst Rev; 2014; 2014(12):CD006991. PubMed ID: 25437000 [TBL] [Abstract][Full Text] [Related]
67. Azithromycin in high-risk, refractory chronic rhinosinusitus after endoscopic sinus surgery and corticosteroid irrigations: a double-blind, randomized, placebo-controlled trial. Maniakas A; Asmar MH; Renteria AE; Nayan S; Alromaih S; Endam LM; Sampalis JS; Desrosiers M Int Forum Allergy Rhinol; 2021 Apr; 11(4):747-754. PubMed ID: 32929891 [TBL] [Abstract][Full Text] [Related]
68. Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps. Lin L; Dai F; Ren G; Wei J; Chen Z; Tang X Am J Otolaryngol; 2020; 41(1):102311. PubMed ID: 31732300 [TBL] [Abstract][Full Text] [Related]
69. Decreased expression of type I (IFN-β) and type III (IFN-λ) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps. Hwang JW; Lee KJ; Choi IH; Han HM; Kim TH; Lee SH J Allergy Clin Immunol; 2019 Dec; 144(6):1551-1565.e2. PubMed ID: 31449915 [TBL] [Abstract][Full Text] [Related]
70. Biologics in chronic rhinosinusitis with nasal polyposis. Laidlaw TM; Buchheit KM Ann Allergy Asthma Immunol; 2020 Apr; 124(4):326-332. PubMed ID: 31830587 [TBL] [Abstract][Full Text] [Related]
71. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404 [TBL] [Abstract][Full Text] [Related]
72. Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis. Cho DY; Skinner D; Mackey C; Lampkin HB; Elder JB; Lim DJ; Zhang S; McCormick J; Tearney GJ; Rowe SM; Woodworth BA Int Forum Allergy Rhinol; 2019 Jun; 9(6):629-637. PubMed ID: 30657641 [TBL] [Abstract][Full Text] [Related]
73. Oral Therapeutics for Rhinosinusitis with Nasal Polyposis. Thomas AJ; Alt JA Adv Otorhinolaryngol; 2016; 79():138-47. PubMed ID: 27466856 [TBL] [Abstract][Full Text] [Related]
74. [Advance in epithelial-mesenchymal transition in chronic rhinosinusitis]. Gao YB; Zhang Y; Zhang L Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Mar; 54(3):231-236. PubMed ID: 30909348 [TBL] [Abstract][Full Text] [Related]
76. Topical Therapies for Refractory Chronic Rhinosinusitis. Sanan A; Rabinowitz M; Rosen M; Nyquist G Otolaryngol Clin North Am; 2017 Feb; 50(1):129-141. PubMed ID: 27888909 [TBL] [Abstract][Full Text] [Related]